©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Expression in High Yield of Pig 11 Na,K-ATPase and Inactive Mutants D369N and D807N in Saccharomyces cerevisiae(*)

(Received for publication, October 2, 1995; and in revised form, November 20, 1995)

Per Amstrup Pedersen Jakob H. Rasmussen Peter L. Jørgensen

From the Biomembrane Research Center, August Krogh Institute, University of Copenhagen, Universitetsparken 13, DK-2100 Copenhagen OE, Denmark

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Studies of structure-function relationships in Na,K-ATPase require high yield expression of inactive mutations in cells without endogenous Na,K-ATPase activity. In this work we developed a host/vector system for expression of fully active pig Na,K-ATPase as well as the inactive mutations D369N and D807N at high levels in Saccharomyces cerevisiae. The alpha1- and beta1-subunit cDNAs were inserted into a single 2-µm-based plasmid with a high and regulatable copy number and strong galactose-inducible promoters allowing for stoichiometric alterations of gene dosage. The protease-deficient host strain was engineered to express high levels of GAL4 transactivating protein, thereby causing a 10-fold increase in expression to 32,500 ± 3,000 [^3H]ouabain sites/cell. In one bioreactor run 150-200 g of yeast were produced with 54 ± 5 µg of Na,K-pump protein/g of cells. Through purification in membrane bound form the activity of the recombinant Na,K-ATPase was increased to 42-50 pmol/mg of protein. The Na,K dependence of ATP hydrolysis and the molar activity (4,500-7,000 min) were close to those of native pig kidney Na,K-ATPase. Mutations to the phosphorylation site (D369N) or presumptive cation sites (D807N), both devoid of Na,K-ATPase activity, were expressed in the yeast membrane at the same alpha-subunit concentration and [^3H]ouabain binding capacity as the wild type Na,K-ATPase. The high yield and absence of endogenous activity allowed assay of [^3H]ATP binding at equilibrium, demonstrating a remarkable 18-fold increase in affinity for ATP in consequence of reducing the negative charge at the phosphorylation site (D369N).


INTRODUCTION

Na,K-ATPase is responsible for the generation and maintenance of transmembrane Na/K ion gradients required for generation of action potentials, control of cell volume, and secondary active transport. The functional Na,K-pump is a heterodimer consisting of one alpha-subunit and one beta-subunit(2) . At least three isoforms of each subunit are expressed in a tissue- and development-specific way. The alpha-subunit isoforms consist of 1,016-1,023 amino acids and traverse the membrane eight to ten times. The beta-subunit is an N-glycosylated protein, consisting of 302 residues, with a single transmembrane domain and three disulfide bonds(3, 4) .

The production of recombinant Na,K-pumps is potentially a powerful approach for study of structure-function relationships, but heterologous expression of membrane proteins like the heterodimeric alphabeta-unit of Na,K-ATPase, with multiple transmembrane segments, has proven to pose special problems. The Na,K-pump has been expressed in the yeast Saccharomyces cerevisiae(1) , COS cells(5) , HeLa cells(6) , NIH 3T3 cells(7) , Xenopus oocytes(8) , and in insect cells(9) . The properties of isozymes of Na,K-ATPase have been analyzed (10, 11) and important structure-function correlates have been established by work on mutants(5, 7, 12, 13) . However, it has been difficult to express Na,K-ATPase in large quantities and higher eucaryotic cell lines like HeLa (6) and COS cells (5) and Xenopus oocytes (8, 14) express endogenous Na,K-ATPase of almost the same magnitude as the transfected activity. The ouabain selection methodology (5, 6) does not allow analysis of the interesting mutants that are blocked in the reaction cycle. The expression level in baculovirus infected insect cells is high, but only a small fraction of the recombinant pumps are enzymatically active, and insect cells also possess endogenous Na,K-ATPase activity(9, 11) . A major advantage of yeast cells for expression studies is their lack of endogenous Na,K-ATPase activity. The work of Farley and co-workers(1, 15, 16) demonstrated that yeast cells are capable of expressing fully active Na,K-ATPase at the cell surface, but the expression is limited to levels of 2-4 pmol/mg of protein as determined by [^3H]ouabain binding.

In the present work the capacity of S. cerevisiae for the production of enzymatically active Na,K-pumps was characterized with respect to the dependence upon gene copy number, promoter strength, and growth medium composition. The alpha1- and beta1-subunit gene dosage was altered in parallel by insertion of their cDNAs into a single plasmid with a particularly high and regulatable copy number. The promoter activity was increased by the combination of a strong galactose regulated promoter and a host strain modified to express high levels of GAL4-transactivating protein(17) . The plasmid was constructed to allow separation of the growth of the host cells from the phase of Na,K-ATPase expression. Computer-controlled bioreactors were used to increase the yield and growth experiments were performed to examine the influence of medium composition and induction time using [^3H]ouabain binding to assess the expression levels. Established methods were modified for partial purification of Na,K-ATPase from the yeast plasma membranes, in conditions where the endogenous H-ATPase was removed. The quantity, ligand binding, and enzymatic properties of the recombinant Na,K-ATPase were determined. The versatility of the expression system was examined by characterization of mutations to two side chains of the alpha-subunit, the D369N mutation of the phosphorylated side chain(7, 18) , and D807N at a presumptive site for cation binding(19) . These mutants were devoid of Na,K-ATPase and potassium-dependent para-nitrophenyl phosphatase activities, but they could be expressed in the yeast membranes at the same alpha-subunit concentration and [^3H]ouabain binding capacity as the wild type Na,K-ATPase. The high yield of Na,K-ATPase from yeast and the absence of endogenous activity allowed assays not previously achieved for recombinant enzyme, such as [^3H]ATP binding at equilibrium.


MATERIALS AND METHODS

Strains and Media

S. cerevisiae strains BJ5457 (alpha ura3-52 trp1 lys2-801 leu2Delta1 his3Delta200 pep4::HIS3 prb1Delta1.6R can1 GAL) (20) and the derivative PAP1500 (alpha ura3-52 trp1:: GAL10-GAL4 lys2-801 leu2Delta1 his3Delta200 pep4::HIS3 prb1Delta1.6R can1 GAL) (this study) were used as host organisms for the expression of the alpha1beta1 pig Na,K-ATPase. Strain PAP1500 was constructed by integrating BglII-digested pPAP1488 into the trp1 locus of BJ5457 by homologous recombination. Southern blotting of restriction endonuclease digested chromosomal DNA isolated from this strain confirmed the presence of the entire GAL10-GAL4 region in the yeast chromosome (data not shown). Transformed PAP1500 cells were selected on synthetic minimal medium containing 2% glucose and supplemented with 30 mg/liter leucine and 20 mg/liter lysine(21) . Transformed BJ5457 were grown in the same medium but additionally supplemented with 20 mg/liter tryptophan. The Escherichia coli K-12 strain XL1-blue (22) was used as host organism for the recombinant DNA work. E. coli strains were grown in LB medium(23) .

Transformation of S. cerevisiae and E. coli

Yeast cells were transformed by electroporation according to Becker and Guarante (24) . E. coli was transformed according to Nishimura et al.(25) .

DNA Techniques

Isolation of plasmid DNA from E. coli was carried out as described by Del Sal et al.(26) . Total DNA was isolated from S. cerevisiae as described by Rose et al.(27) . Restriction endonucleases and DNA modifying enzymes were purchased from New England Biolabs, Boehringer Mannheim, and Promega and used according to the manufacturers' specifications. Common DNA manipulations were carried out as described by Sambrook et al.(28) . Southern blots were developed using a biotinylated, nick-translated probe prepared as described by the manufacturer Tropix.

Plasmid Constructions

Full-length cDNA clones encoding the pig alpha1-subunit (plasmid pGC35) and the beta1-subunit (plasmid pNKbeta31) were kindly provided by K. Petrukhin, Columbia University, New York(29) . The S. cerevisiae-E. coli shuttle vector pEMBLyex4 has been described previously (30) as has pKHint-C(17) , pUC19(31) , pEMBLYr25(32) , and RS421(33) . The 3.4-bp (^1)XbaI-alpha1-HindIII fragment from pGC35 was inserted into XbaI-HindIII-digested pEMBLyex4. The remaining polylinker region 5` to the XbaI site was removed by T4 DNA polymerase treatment and ligation after SacI-XbaI digestion. The resulting plasmid was digested with HindIII, Klenow polymerase-treated, and religated to remove the unique HindIII site. A 10-bp HindIII linker (double-stranded decamer (dCGAAGCTTCG) (Boehringer Mannheim) was inserted into the unique NaeI site. The resulting alpha1 expression plasmid carries the alpha1 pig cDNA under control of the CYC-GAL promoter.

The Klenow polymerase-treated 941-bp NcoI-beta1-DraI fragment from pNKbeta31 was ligated into XhoI-digested, Klenow polymerase-treated RS421. The resulting plasmid carries the NcoI-beta1-DraI fragment between the PMA1 (yeast H-ATPase) promoter and terminator region. The promoter-beta1-terminator region present on a HindIII fragment was cloned into the unique HindIII site in pEMBLyex4 in the correct orientation with respect to the CYC-GAL promoter. A 1,637-bp NruI-HpaI fragment was excised from the plasmid to eliminate one of three KpnI sites. The resulting plasmid was digested with KpnI and religated to remove the PMA1 promoter from the plasmid. The resulting beta1 expression plasmid contains the pig beta1 cDNA under control of the CYC-GAL promoter. The final alpha1beta1 expression plasmid, pPAP1466, carries the 5.0-kilobase NruI-CYC-GAL-beta1-HindIII fragment inserted into the NruI-HindIII-digested alpha1 expression plasmid.

The plasmid pPAP1647 contains the NheI-URA3-Amp-BglI fragment from pYES2.0 and the NheI-P15A ori-Amp-BglI fragment from pACYC177 (34) . The ScaI-P15A ori-ScaI fragment from pPAP1647 was cloned into ScaI-digested pEMBLyex4. The resulting plasmid pPAP1657 has a 100-fold lower copy number in E. coli compared with pEMBLyex4. The alpha1beta1 expression plasmid pPAP1666 carries the ApaI-P15A ori-AatII fragment from pPAP1657, the ApaI-alpha1-AatII fragment, and the AatII-beta1-AatII fragment from pPAP1466. The resulting alpha1beta1 expression plasmid has a 100-fold lower copy number in E. coli compared to pPAP1466.

The plasmid pPAP1485 bears the 3.4-kilobase pair EcoRI-GAL10-GAL4-HindIII fragment from pKHint-C inserted into EcoRI and HindIII-digested pUC19. pPAP1488 was constructed by inserting the 850-bp EcoRI-TRP1-EcoRI fragment from pEMBLYr25 into EcoRIdigested pPAP1485.

Site-directed Mutagenesis

Site-directed mutagenesis was performed according to Ho et al.(35) . The nucleotide sequences of the two D369N mutagenic primers were; 5` CAT CTG CTC AAA CAA AAC CGG 3` and 5` CCG GTT TTG TTT GAG CAG ATG 3`. The mismatched nucleotide changing Asp to Asn is underlined. A fragment containing the mutation was subsequently cloned into the expression plasmid pPAP1466. The nucleotide sequences of the two D807N mutagenic primers were; 5` GGA ACC ATG TTT GTG CCC AAG 3` and 5` CTT GGG CAC AAA CAT GGT TCC 3`. The mismatched nucleotide changing Asp to Asn is underlined. A restriction fragment containing the mutation was subsequently cloned into the expression plasmid pPAP1666. The DNA sequences of the entire PCR fragments were confirmed by dideoxy sequencing.

Induction of Na,K-Pump Synthesis

A single colony of transformed yeast cells was selectively propagated until saturation in 10 ml of glucose minimal medium supplemented with leucine(21) . Aliquots of 5 ml were subsequently propagated in 100 ml of minimal medium lacking leucine. For small scale production, 10 ml of this preculture were used for inoculation of 3 liters of selective minimal medium containing 0.5% glucose and 2% lactate as carbon source and supplemented with all amino acids except leucine, tryptophan, and histidine. Galactose was added to a final concentration of 2% at A = 1.0. Routinely, cells were harvested 48 h after addition of galactose.

For large scale production, 1000 ml of preculture was used to inoculate 10 liters of minimal medium in an Applicon® fermentor equipped with an ADI 1030 Bio Controller. The culture was agitated at 158 rpm, and air was supplied through a 0.2-µm filter. The carbon source was 5% glucose and 2% lactate, and the medium was supplemented with all amino acids except leucine, tryptophan, and histidine. During growth at 30 °C in glucose, the pH of the medium was kept at 6.0 by computer-controlled addition of 1 M NaOH. The shift from growth on glucose to growth on lactate was monitored as an increase in pH of the growth medium and a decrease in growth rate. At this point galactose was added to a final concentration of 2%. Cells were harvested after 48 h.

Isolation of Yeast Membranes

Galactose-induced yeast cells were harvested at 5,800 g for 30 min and washed once in ice-cold water. Yeast cells were resuspended in ice-cold lysis buffer (25 mM imidazole, 1 mM EDTA, 1 mM EGTA, 10% (w/v) sucrose, pH 7.5) containing 1 mM PMSF, 1 µg/ml chymostatin, 1 µg/ml pepstatin, and 1 µg/ml leupeptin. Cells were homogenized in an ice-cold Bead Beater (Biospec) for three times 1 min. The homogenate was centrifuged at 1000 times g for 10 min at 4 °C. The supernatant was further centrifuged at 3,000 times g for 20 min at 4 °C. The final supernatant was centrifuged at 100,000 times g for 1.5 h at 4 °C. The resulting crude membrane fraction was homogenized in a Teflon-glass Braun homogenizer in ice-cold lysis buffer containing the previously mentioned concentrations of protease inhibitors and kept at -80 °C until use.

Gradient Membranes

Crude membranes were fractionated on step gradients consisting of 15 ml of 40% plus 15 ml of 15% (w/v) sucrose in lysis buffer with proteolysis inhibitors. A sample of 6-8 ml containing 40 mg of protein was layered on top, and the gradient was centrifuged for 2 h at 50,000 rpm in the Ti-60 Beckman rotor. The membrane band at the 15/40% interface containing 20-30% of sample protein in 6 ml was collected in a syringe, diluted 5-fold in lysis buffer, and collected by centrifugation at 2 h at 50,000 rpm.

Electrophoretic Analysis and Immunological Techniques

Protein samples were mixed with 2-fold concentrated loading buffer containing 1 mM PMSF and 1 µg/ml chymostatin and incubated for 10 min at room temperature, prior to separation in 8% polyacrylamide gels(36) . Western blotting was performed according to Kyhse-Andersen (37) using a polyclonal anti-alpha-antibody (anti-KETYY) kindly provided by Jack Kyte, University of California. For quantitative determinations of Na,K-ATPase proteins, Western blots were digitalized on an HP-Scanjet IIP scanner, and densitometry was performed using the Cream software from KemEnTech, Copenhagen, Denmark.

Selective SDS Treatment of Crude Yeast Membranes and Purification of Na,K-ATPase

Yeast membranes were treated with SDS as before (38, 39) . The final concentration of the solution was 0.64 mg/ml SDS, 2 mg/ml protein, 3.0 mM Na(2)ATP, 25 mM Imidazole/HCl, 1 mM Na(2)EDTA, pH 7.5, and 1 mM PMSF, 1 µg/ml chymostatin, 1 µg/ml pepstatin, and 1 µg/ml leupeptin to prevent proteolysis. The SDS-treated membranes were loaded on a step gradient containing two layers of 10 and 37% (w/v) sucrose in the 35-ml tubes of the Beckman Ti-60 angle rotor and separated by centrifugation for 2 h at 40,000 rpm. A band of 6 ml was collected from the interface of 10 and 37% sucrose through a needle mounted on a syringe, and Na,K-ATPase was collected as a pellet after 3-5 fold dilution and centrifugation at 40,000 rpm overnight.

For ATP binding experiments, gradient membranes were incubated at 2 mg of protein/ml in lysis buffer with 0.3 mg/ml SDS and proteolysis inhibitors for 30 min at 20 °C. The mixture was centrifuged for 30 min at 70.000 rpm in the Beckman 100 A ultracentrifuge and resuspended in lysis buffer.

Equilibrium [^3H]Ouabain Binding to Isolated Membranes

100-200 µg of yeast membrane protein was incubated at 37 °C for 1 h in 3 mM MgSO(4), 1 mM NaTris(2)VO(4), 1 mM EGTA, 10 mM MOPS-Tris, pH 7.2, in the presence of 10 nM [^3H]ouabain (Amersham Corp., specific activity: 36 Ci/mmol), varying concentrations of cold ouabain, and 1 mM PMSF, 1 µg/ml chymostatin, 1 µg/ml pepstatin, and 1 µg/ml leupeptin to prevent proteolysis. After standing at 4 °C for 20 min, bound and unbound ouabain were separated by centrifugation in the Beckman 100 A centrifuge at 70,000 rpm for 30 min at 4 °C. Samples were washed twice in ice-cold binding buffer and centrifuged for 10 min at 70,000 rpm. The amount of bound [^3H]ouabain was determined by scintillation counting.

Equilibrium [^3H]Ouabain Binding to Intact Yeast Cells

Aliquots containing 10 mg of intact yeast cells were incubated at 37 °C for 1 h in 1 M sorbitol, 3 mM MgSO(4), 1 mM NaTris(2)VO(4), 1 mM EGTA, 10 mM MOPS-Tris, pH 7.2, in the presence of 10 nM [^3H]ouabain (Amersham) and varying concentrations of cold ouabain. After standing at 4 °C for 20 min, bound and unbound ouabain were separated by centrifugation in an Eppendorf centrifuge at 3,000 rpm for 5 min at 4 °C. Samples were washed once in ice-cold binding buffer. The amount of bound [^3H]ouabain was determined by scintillation counting.

Equilibrium ATP Binding

Aliquots of 100-200 µg of SDS-treated gradient membranes were incubated at 0-4 °C in 1 ml containing either 10 mM NaCl or 10 mM KCl, 10 mM MOPS-Tris, pH 7.2, 10 mM EDTA-Tris, and [^3H]ATP (Amersham, specific activity: 36 Ci/mmol) and ATP-Tris to final concentrations of 0.2-300 nM. Bound and unbound [^3H]ATP were separated by centrifugation at 100,000 times g for 30 min at 4 °C. The supernatant was discharged and remaining buffer removed with a paper towel. Bound [^3H]ATP was determined by scintillation counting, and specific binding was calculated as binding in presence of NaCl minus binding in presence of KCl.

ATPase Assay

For assay of Na,K-ATPase activity 10-µl aliquots containing 50-100 µg of protein were transferred to tubes containing 0.5 ml of 130 mM NaCl, 20 mM KCl, 3 mM MgCl(2), 3 mM ATP, with or without 1 mM ouabain, 10 mM MOPS-Tris, pH 7.5, at 37 °C. After incubation for 1, 3, 5, or 10 min at 37 °C, the reaction was stopped with 1 ml of ice-cold 2% H(2)SO(4), 0.1% ascorbic acid, 0.5% ammonium heptamolybdate, and 0.5% SDS. The tubes were left at room temperature for 15 min, and absorbance was measured at 690 nm as before(39) . The Na,K-ATPase activity was calculated from the difference in absorbance for tubes with and without 1 mM ouabain.

For assay of vanadate sensitive H-ATPase activity(33) , 10-µl portions were transferred to test tubes containing 1 ml of 50 mM MES adjusted to pH 6.5 with Tris, 5 mM MgSO(4), 50 mM KNO(3) (to inhibit vacuolar ATPase), 5 mM sodium azide (to inhibit mitochondrial ATPase) 0.2 mM ammonium molybdate (to inhibit acid phosphatase), and 2 mM Na(2)ATP without and with 1 mM NaVO(3). After 10 min at 37 °C, the reaction was stopped, and inorganic phosphate was measured as described above for Na,K-ATPase.

Molecular sieve high performance liquid chromatography was performed with a TSK 3000 SW (7.5 times 300 mm) Toyo Soda gel filtration column with a TSK SW guard column (7.5 times 75 mm) operated at flow rates of 0.2 ml/min using a Pharmacia Biotech Inc. solvent delivery system as before (40) . Prior to solubilization, the membrane-bound Na,K-ATPase was sedimented at 100,000 rpm for 10 min in the Beckman Airfuge and resuspended in 300 mM potassium acetate, pH 6.0, 2 mM dithiothreitol, 2 mM EDTA-Tris. This suspension was mixed with equal volumes of CE(8), 10 mg/ml. The insoluble residue was removed by centrifugation for 10 min at 100,000 rpm in a Beckman Airfuge(40) .


RESULTS

Development of a Host/Vector System for Na,K-ATPase Expression in S. cerevisiae

In the 2-µm-based plasmids constructed for expression of the pig Na,K-ATPase, pPAP1466 and pPAP1666, the cDNAs encoding the alpha1- and beta1-subunits are transcribed from identical CYC-GAL promoters to avoid nonstoichiometric transcription of the two subunit genes (Fig. 1). The CYC-GAL promotor is a strong galactose-inducible hybrid promoter containing the DNA sequences required for constitutive cytochrome c(1) (CYC1) expression and the upstream activating sequence from the GAL1-GAL10 intergenic promoter region(32) . The 2-µm origin of replication assures that the expression plasmid is stably maintained in the yeast cell. The expression plasmid carries two selective markers, URA3 and the poorly expressed allele of the LEU2 gene, leu2-d. A plasmid with two selective markers was favored for two reasons. First, manipulation of the plasmid copy number by altering the composition of the growth medium was facilitated, and second, homologous recombination between the identical CYC-GAL promoter regions transcribing the alpha1- and beta1-subunits, with loss of one of the subunit genes, was avoided. Selection for uracil autotrophy produces transformants with a plasmid copy number of around 20, while selection for both leucine and uracil autotrophy selects for growth of yeast cells with an extraordinary high copy number of around 200(41) .


Figure 1: Structural map of the 15.7-kilobase yeast alpha1beta1 expression plasmids, pPAP1466 and pPAP1666. Abbreviations used: alpha1(pig), the alpha1-subunit cDNA from the pig kidney Na,K-ATPase; beta1(pig), the beta1-subunit cDNA from pig kidney Na,K-ATPase; CYC-GAL P, a hybrid promoter containing the GAL10 upstream activating sequence fused to the 5`-nontranslated leader of the cytochrome-1 gene; 2µ, the 2-µm origin of replication; URA3, the orotitin-5`-P decarboxylase gene; leu2-d, a poorly expressed allel of the beta-isopropylmalate dehydrogenase gene; pMB1, the pMB1 origin of replication; P15A, the P15A origin of replication. Amp, a beta-lactamase gene; T, the PMA1 (H-ATPase from yeast) terminator region. Arrows indicate the direction of transcription.



The two expression plasmids differ in their E. coli origin of replication in that pPAP1466 is a pUC derivative (31) with a very high copy number, while pPAP1666 is a P15A-derived plasmid (34) with a 100-fold reduced copy number in E. coli compared with pPAP1466. The use of pPAP1666 with a low copy number in E. coli was necessary, as we were unable to clone various alpha1-subunit mutations into pPAP1466.

The yeast strain BJ5457(20) , lacking the PEP4 and PRB1 protease activities, was chosen as the basic host strain for the production of recombinant Na,K-ATPase in order to reduce the possibility of proteolytic degradation of the enzyme during synthesis and purification. The transactivating GAL4 protein is known to be limiting for expression controlled by galactose-regulated promoters(17) . The GAL4 protein level can be increased by integrating a GAL10-GAL4 transcriptional fusion into the yeast chromosome(17) . Therefore, we constructed the yeast-integrating plasmid pPAP1488 (Fig. 2), which was targeted to the trp1 locus of BJ5457 by homologous recombination generating strain PAP1500. Addition of galactose to PAP1500 transformed with pPAP1466 or pPAP1666 should initiate a cascade reaction leading to expression of GAL4 protein and Na,K-ATPase alpha1- and beta1-subunits.


Figure 2: Structural map of the 6.6-kilobase yeast integrating plasmid pPAP1488. Abbreviations used: GAL10 P, the GAL10 promoter; GAL4, the GAL4 transactivator gene; TRP1, the PR-antranilate isomerase gene; pMB1, the pMB1 origin of replication; Amp, a beta-lactamase gene. The arrow indicates the direction of transcription.



Growth Physiology and Kinetics of Na,K-ATPase Expression in Yeast

The physiological effect of expression of the Na,K-ATPase on growth of yeast cells was determined in a series of growth experiments with PAP1500(pPAP1466). Fig. 3illustrates how the yeast growth phase was separated from the Na,K-ATPase expression phase. In the growth phase, the level of Na,K-ATPase expression is low due to the absence of galactose. Later in the growth phase, the cells were grown with lactate as carbon source to avoid repression by glucose of the CYC-GAL promoters during the galactose-induced phase of Na,K-ATPase synthesis. In Fig. 3the cells were grown under inducing and noninducing conditions in media selecting for a high plasmid copy number. Growth of the transformed yeast cells ceased immediately after induction of Na,K-pump biosynthesis with galactose whether the cells were expressing wild type or the D369N and D369A mutations.


Figure 3: Separation of the yeast growth phase and the Na,K-pump production phase: without galactose induction (circle and with addition of galactose 2% (bullet. Growth of PAP1500(pPAP1466) was in minimal medium at 30 °C with 0.5% glucose or 2% lactate as carbon source. Yeast cells were growing exponentially with glucose as carbon source between A = 0.04 and A = 0.5 and exponentially with lactate as carbon source between A = 0.5 and A = 1.0. Induction of Na,K-pump biosynthesis with 2% galactose at A = 1.0 and higher is seen to arrest cell growth. Abbreviations: GLU, growth on glucose; LAC, growth on lactate; GAL, addition of galactose to a final concentration of 2%.



Integration of a GAL10-GAL4 transcriptional fusion in the yeast chromosome had a dramatic effect on the level of expression of Na,K-ATPase, in media selecting for the high plasmid copy number. Fig. 4shows that induction of Na,K-ATPase was much faster and that the maximal number of [^3H]ouabain binding sites was about 10-fold higher in cells with the chromosomal fusion than in the yeast strain, with only a few copies of GAL4 protein/cell.


Figure 4: The accumulation of [^3H]ouabain sites in the membranes of yeast strains without () or with (bullet) a transcriptional GAL10-GAL4 fusion. At the indicated times 80-ml aliquots of the growth medium were removed and crude cell membranes were prepared. Aliquots containing 200 µg of protein were assayed for binding at 10 nM [^3H]ouabain as described under ``Experimental Procedures.''



A number of experiments were performed to determine the influence of composition of the growth medium and induction time on the time course of appearance of high affinity [^3H]ouabain sites measured in crude yeast membranes. Fig. 5shows that the highest density of [^3H]ouabain sites is seen in yeast cells, with a high copy number of the expression plasmid, and growing in synthetic minimal medium supplemented with all amino acids except leucine, tryptophan, and histidine. In medium without the supplement of amino acids, accumulation of Na,K-ATPase ceased after 48 h, and then the level decreased, suggesting that low levels of amino acids may be rate-limiting for synthesis of Na,K-ATPase.


Figure 5: Effect of composition of growth medium on accumulation of ouabain sites. Crude yeast membranes were isolated from strain PAP1500(pPAP1466) after induction with 2% galactose at time 0. Procedures for membrane preparation and [^3H]ouabain binding were as in Fig. 4. Cells were grown with 0.5% glucose and 2% lactate as carbon source prior to induction, as illustrated in Fig. 3. Abbreviations used: - leu - aa, growth in the absence of leucine and the presence of lysine; + leu - aa, growth in the presence of leucine and lysine; -leu + aa, growth medium supplemented with all amino acids except leucine, tryptophan, and histidine.



Purification and Characterization of Na,K-ATPase from Crude Yeast Cell Membranes

Under optimum growth conditions in the computer-controlled bioreactor, the yield of yeast was 150-200 g/10 liters of culture, and the concentration of [^3H]ouabain sites was 323 ± 31 pmol/g cells (mean ± S.E., n = 5 preparations). This value corresponds to 32,500 ± 3,000 sites/cell. The density of sites was the same in the intact transformed yeast cells as in spheroplasts after removal of the cell wall by lyticase (data not shown).

In crude yeast membranes, the binding capacity for [^3H]ouabain was 10-15 pmol/mg of protein. For characterization of the recombinant enzyme, it was essential to reduce the endogenous H-ATPase activity and to purify the enzyme by removal of extraneous protein. Fig. 6shows the SDS curve required for application of the purification scheme developed previously for purification of the Na,K-ATPase from kidney(38, 39) . In contrast to the 3-5-fold activation of Na,K-ATPase in kidney membranes after incubation with SDS, due to demasking of closed right-side-out vesicles, the activity of Na,K-ATPase or H-ATPase in yeast cell membranes increased only about 20%. At the membrane protein concentration of 2 mg/ml, an optimum concentration range for SDS was found (0.5-0.7 mg/ml) where most of the H-ATPase of the yeast cell membranes was inactivated, while [^3H]ouabain binding and Na,K-ATPase activity of the recombinant enzyme were preserved. The peak of [^3H]ouabain binding in crude yeast cell membranes was found at equilibrium densities in the range 1.15-1.2 g/ml(42) . However, after incubation with 0.64 mg/ml SDS, it was difficult to recover the recombinant Na,K-ATPase after centrifugation in discontinuous sucrose gradients, because the activity was distributed in a broad band at relatively low densities around 1.10 g/ml. The [^3H]ouabain binding data in Fig. 7show a 3-5-fold enrichment of binding capacity from 10-15 pmol/mg [^3H]ouabain binding in crude yeast membranes to 42-50 pmol/mg of protein in the partially purified preparation. Note that the dissociation constant was reduced from 21 ± 2 nM to 11 ± 2 nM upon incubation with SDS and fractionation, presumably because the detergent promotes the access of the ligands, Mg and vanadate, required for facilitation of [^3H]ouabain binding.


Figure 6: Demasking and inactivation of H-ATPase (bullet) and [^3H]-ouabain binding () of crude yeast cell membranes during incubation with SDS in presence of ATP. Membrane protein at 4 mg/ml was incubated at 20 °C in 200 µl with SDS at the indicated concentrations in a medium containing 1 mM EDTA, 3 mM Na(2)ATP, 10 mM MES-Tris, pH 7.0. For assay of vanadate-sensitive H-ATPase activity, 10-µl portions were transferred to test tubes and analyzed as described under ``Materials and Methods.'' For assay of [^3H]ouabain binding, portions of 25 µl containing 100 µg of membrane protein were transferred to centrifuge tubes containing 1 ml of binding medium with 10 nM [^3H]ouabain without or with 1 mM unlabeled ouabain. Other components and separation of free and bound ligand were as described under ``Materials and Methods.''




Figure 7: Scatchard plots of [^3H]ouabain binding to crude yeast cell membranes isolated from strain PAP1500(pPAP1466) (bullet) and partially purified recombinant Na,K-ATPase (). Aliquots of the preparations containing 100-200 µg of protein were incubated with [^3H]ouabain and unlabeled ouabain at final concentrations ranging from 10.8 to 161 nM. The data were fitted by nonlinear least squares regression (line). The K and binding capacities were 21 ± 2 nM and 10.0 ± 0.5 pmol/mg of protein for the crude membranes and 11 ± 2 nM and 44 ± 2 pmol/mg of protein for the purified Na,K-ATPase.



A higher yield, but a lower binding capacity (15-25 pmol/mg of protein, cf. Fig. 12), were obtained when the crude membranes were fractionated on sucrose gradients prior to SDS incubation. The gradient membranes at the interphase between 15 and 40% (w/v) sucrose were collected by centrifugation and subsequently incubated at 2 mg of protein/ml with SDS in a lower concentration, 0.5 mg/ml SDS in the presence of 3 mM ATP, or at 0.3 mg/ml SDS in the absence of ATP.


Figure 12: Scatchard plot of [^3H]ATP binding to SDS-treated gradient membranes of wild type and mutant D369N recombinant Na,K-ATPase. Procedures for preparation of gradient membranes, incubation with SDS, and assay of [^3H]ATP in NaCl or KCl medium were as described under ``Materials and Methods.'' The data were fitted by nonlinear least squares regression to the lines with K -109 ± 11 nM and a binding capacity of 14.1 ± 0.8 pmol/mg of protein for wild type (WT) and K -5.9 ± 0.4 nM and a binding capacity of 21 ± 1 pmol/mg of protein for D369N.



Fig. 8shows a comparison of Western blots of the recombinant Na,K-ATPase from this preparation and renal Na,K-ATPase. From this comparison, the purity in terms of alpha-subunit protein was 0.71% (7.1 µg of alpha-subunit protein/mg of SDS-extracted yeast membrane protein). The purity in terms of [^3H]ouabain sites was 0.65%, corresponding to 44 pmolbulletmg protein/6.8 nmolbulletmg protein times 100. The similarity of the two values suggests that the unit binding one molecule of [^3H]ouabain contains one recombinant alpha-subunit. The Na- and K-ion dependence of ATP splitting in Fig. 9is identical to that observed before for preparations from pig kidney. The molecular activity of Na,K-ATPase in the preparation was 4,500-7,000 P(i)bulletmin per [^3H]ouabain site. This value is in the lower range of the molecular activity of the native pig kidney Na,K-ATPase (7,000-8,000 P(i)bulletmin).


Figure 8: Western blot of SDS-extracted membranes from yeast cells. Recombinant wild type alphabeta-units (lanes a-e), recombinant D369N alphabeta-units (lanes j-m), recombinant D807N alphabeta-units (lanes r-u) partially purified pig kidney Na,K-ATPase (lanes f-i, n-q, and v-z) after separation by SDS-polyacrylamide gel electrophoresis. The amount of pig kidney Na,K-ATPase is calculated as µg alphabeta-units assuming one alphabeta-unit per [^3H]ouabain binding site ((35) ) as determined from Scatchard analysis, see ''Materials and Methods.`` Protein in lanes a, j, and r, 0.48 µg; in lanes b, k, and s, 1.0 µg; in lanes c, l, and t, 5.0 µg; in lanes d, n, and u, 10.0 µg; and in lane e, 20.0 µg. Na,K-ATPase alphabeta-unit in lanes f, n, and v, 0.016 µg; in lanes g, o, and x 0.031 µg; in lanes h, p, and y, 0.078 µg; and in lanes i, q, and z, 0.156 µg. Arrows indicate the position of the alpha-subunit. From this standardization, the purity in terms of alpha-subunit protein was estimated from scans of the blots to be 0.71% for wild type, 0.68% for D369N, and 0.54% for D807N.




Figure 9: Na,K-ATPase activity of partially purified recombinant Na,K-ATPase as a function of Na and K concentrations. The reaction mixture contained 3 mM ATP at pH 7.5 and 37 °C. Isotonicity was maintained by exchanging NaCl and KCl in the medium for assay of Na,K-ATPase described under ``Materials and Methods.''



Chromatography of soluble Na,K-ATPase in CE(8) on TSK 3000 SW size exclusion columns was shown to be a sensitive procedure for detecting the aggregation of alphabeta-units accompanying thermal denaturation of Na,K-ATPase(40) . In the experiment in Fig. 10, it is seen that the [^3H]ouabain complex of soluble, wild type, recombinant Na,K-ATPase is stable during chromatography in CE(8) at 2-4 °C and that it elutes quantitatively at a volume (9.0 ml) corresponding to the elution volume (8.5 ml) of the [^3H]ouabain complex with the alphabeta-unit of kidney Na,K-ATPase. The elution volume of the D369N mutant alphabeta-unit was in the same range (9.0 ml). This provides evidence for organization of the recombinant, wild type, and mutant D369N, Na,K-ATPase in alphabeta-units with hydrodynamic properties similar to those of native renal Na,K-ATPase. There was no tendency for aggregation of the soluble protein to oligomers similar to the (alpha-alpha) aggregates demonstrated in solubilized preparations of the recombinant alpha-subunit from SF9 cells infected with baculovirus (43) .


Figure 10: Size-exclusion chromatography of recombinant Na,K-ATPase. The method was as described in (40) using 7.5 times 300-mm plus 7.5 times 75-mm TSK-gel G 3000 SW column equilibrated with CE(8), 5 mg/ml, in 150 mM potassium acetate, pH 6.0, and operated at 0.2 ml/min at 4 °C. Prior to solubilization in CE(8) ((40) ), Na,K-ATPase was incubated with 100 nM [^3H]ouabain, 3 mM MgSO(4), and 1 mM NaTris(2)VO(4) as in (39) .



Expression of Recombinant Na,K-ATPases without Turnover

We constructed two mutants in the alpha1 pig subunit by site-directed mutagenesis to determine the versatility of the expression system. The D369N mutation exchanges the aspartic acid phosphorylated during the reaction cycle for an asparagine, while the D807N mutation exchanges an aspartic acid potentially involved in cation binding for an asparagine. As expected both D369N (7, 18) and D807N (19) were devoid of Na,K-ATPase and K-p-nitrophenyl phosphatase activity, and D369N was not phosphorylated from ATP (data not shown). Quantitative Western blotting (Fig. 8) showed that both mutations are expressed with the same concentration of alpha-subunit protein in the membrane as the wild type enzyme. Comparison with the purity estimated from [^3H]ouabain binding also shows that the stoichiometry is one ouabain site/alpha-subunit for the two mutants. Data in Fig. 11show that D369N and D807N had the same maximum binding capacity for [^3H]ouabain as the wild type enzyme. The apparent affinity for ouabain of D807N (K(D) = 13 ± 2 nM) was higher than for wild type Na,K-ATPase (K(D) = 21 ± 2 nM), while that of D369N (K(D) 273 ± 13 nM) was much reduced. When the binding assay was conducted in the absence of vanadate, the mutant D369N and the wild type had dissociation constants in the same range (not shown) as an indication that D369N did not interact with vanadate. This agrees with the previous observation that D369N does not react with inorganic phosphate(7) .


Figure 11: Scatchard plots of [^3H]ouabain binding to wild type Na,K-ATPase (circle) and the mutants (bullet) D369N and D807N in medium containing MgSO(4) plus vanadate. Aliquots of the preparations containing 100-200 µg of protein were incubated for 60 min at 37 °C with [^3H]ouabain as described under ``Materials and Methods.'' The data were fitted by nonlinear least squares regression (lines) to give the following capacities and dissociation constants (K): D807N, 10.5 ± 0.4 pmol/mg of protein and 13 ± 2 nM; wild type (WT), 10.0 ± 0.5 pmol/mg of protein and 21 ± 2 nM; D369N, 10.9 ± 0.3 pmol/mg of protein and 279 ± 13 nM.



Effects of Mutations to Aspon the Affinity for [^3H]ATP Binding

The high yield of the preparation of recombinant Na,K-ATPase from yeast allowed assays not previously achieved for recombinant Na,K-ATPase, such as [^3H]ATP binding at equilibrium (cf. (44) ) with the possibility of examining the effect of mutations on the binding constant of ATP to the E(1) conformation. In agreement with the known properties of renal Na,K-ATPase(2, 44) , addition of NaCl up to 10 mM did not alter binding of [^3H]ATP to wild type or D369N in MOPS-Tris buffer, since both the unliganded and the Na-bound E(1) form of Na,K-ATPase have high affinities for ATP (K(a) 0.1-0.2 µM). In contrast titration with KCl strongly reduced the level of binding of [^3H]ATP at 10 nM with K 0.13 mM KCl for wild type and 0.2 mM KCl for D369N, reaching a steady state level at 3 mM KCl (data not shown). The explanation for this is that KCl stabilizes the E(2)K form of Na,K-ATPase with affinities for ATP (K 400 µM) (2, 44) that are much higher than the range of [^3H]ATP concentrations (0.2-300 nM) that are used in the binding assay. Specific binding of ATP to the recombinant enzymes can thus be determined as the binding at 10 mM NaCl minus that in medium containing 10 mM KCl as in Fig. 12. This data, in combination with the titration with cations, confirm that the mutant D369N has retained the ability to form the alternative conformations E(1)Na in NaCl or E(2)K in KCl medium where specific [^3H]ATP binding is abolished.

The data in Fig. 12show that linear Scatchard plots were obtained for both wild type and the mutant D369N and that the mutation D369N led to a remarkable change in dissociation constant of the protein-ATP complex. The capacities for binding were in the same range as the capacities for [^3H]ouabain binding and the concentrations of alpha-subunit protein (cf. Fig. 8), suggesting that there was one high affinity binding site for ATP or ouabain per alphabeta-unit (cf. (39) ). However, the dissociation constant for wild type (109 ± 11 nM) was 18-fold higher than for the D369N mutant (5.9 ± 0.4 nM) (Fig. 12) and 32-fold higher than for the D369A mutant (3.4 ± 0.3 nM, data not shown).


DISCUSSION

The concept behind the host/vector system for Na,K-ATPase expression in this study was to separate the phase of yeast cell growth with low basal expression from the expression phase, where the expression level of Na,K-ATPase in the yeast cell membranes increases to a maximum. In the latter phase, the expression system allowed for a high gene copy number and a high transcriptional activity due to the strong inducible promoter. Precise alteration of the alpha:beta gene dose required that the alpha and beta cDNAs be present on the same plasmid and be expressed under control of identical promoters. A regulated increase in plasmid copy number in the Na,K-ATPase production phase was possible, due to the presence of a URA3 gene and the poorly expressed leu2-d gene on the expression plasmid. Selection for leucine autotrophy increased the plasmid copy number and simultaneously elevated the pump concentration 2-3-fold (Fig. 5). This change is smaller than the 8-fold increase in expression of schistosomal antigen P28-I observed upon changing from selecting for uracil to leucine autotrophy(45) . However, these data are not directly comparable as the schistosomal antigen is a soluble protein, while Na,K-ATPase is inserted into the membrane. Transcriptional activity was increased by engineering the yeast host strain to express elevated concentrations of the GAL4-transactivating protein, causing a 10-fold increase in the expression level (Fig. 4). This is consistent with the finding of Schultz et al.(46) who reported a 10-fold increase in the expression level of the membrane bound Epstein-Barr virus gp350 protein after integration of a GAL10-GAL4 fusion into the genome of the yeast host strain. The high transcriptional activity may cause subsequent steps in the synthesis process to become rate-limiting and account for the 2-fold increase in expression level upon supplementing the yeast growth medium with amino acids (Fig. 5).

The combined effect of engineering these parameters was to increase the density of Na,K-pumps to 32,500 ± 3,000 sites/cell or 54 ± 5 µg of Na,K-pump protein/g of yeast cell. In the crude membrane fraction from the yeast (10-15 pmol/mg of protein) and in the SDS-extracted membranes (42-50 pmol/mg of protein), the pump density was higher than achieved previously in eucaryotic cells, cf. Table 1. The recombinant enzyme is fully active, with one site for binding of ATP and ouabain per alpha-subunit and a range of molecular activities close to those of the native Na,K-ATPase of pig kidney. The relatively high activity and the lack of endogenous background allowed for analyses not previously achieved for recombinant Na,K-ATPase, such as ATP binding at equilibrium.



An important reason for separating the growth phase from the phase of Na,K-ATPase biosynthesis is the apparent toxicity of Na,K-ATPase protein synthesis. The evidence for this is the immediate arrest of cell growth and division following the galactose induction of Na,K-ATPase biosynthesis. This could be due to the activity of the Na,K-pump, but arrest of cell growth was independent of the enzymatic activity of the expressed pump as yeast strains expressing wild type or inactive mutations behaved identically. Also, the expression levels obtained in this work do not, in general, prohibit yeast cell growth. Much higher levels of constitutive heterologous expression has been described for soluble proteins(47) . Also the endogenous GAL1 protein accumulates to 0.8% of total cell protein after galactose induction without affecting cell viability(48) . It is therefore reasonable to propose that the toxicity of Na,K-ATPase protein synthesis is due to perturbation of the yeast membranes following the insertion of protein with hydrophobic membrane-embedded sequences. Previous experiments with membrane proteins, OmpA (49) and alpha-hemagglutinin(50) , demonstrated selection against the production of hydrophobic intramembrane segments in response to the poor tolerance by the host cell. Selection for low expressing variants has been observed in several cases, where constitutive promoters were used to drive expression of membrane proteins(51, 52) . In the present expression system, the selection pressure was avoided through the use of a strong inducible promoter, but the toxicity of the expression suggests that the capacity of the yeast membrane system may set the limit for the concentration of Na,K-ATPase that can be achieved in these cells.

The highest expression level of an ATPase in yeast has been described for isoforms of the Arabidopsis thaliana H-ATPase using a multicopy plasmid and the strong constitutive yeast PMA-1 (plasma membrane H-ATPase) promoter(33) . This expression system directs the plant proton pump to the endoplasmic reticulum membranes, where it constitutes 45% of the endoplasmic reticulum proteins, but the plant proton pump may also complement the proton pump in the yeast plasma membrane(53) , like the Neurospora H-ATPase(54) . In our experience, insertion of alphabeta-unit cDNA in this plasmid did not lead to expression of significant amounts of Na,K-ATPase. (^2)The constitutive PMA-1 host/vector system (33) also proved inefficient for expression of the SR-Ca-ATPase(55) . The Na,K-ATPase expression system in yeast described by Horowitz et al.(1) also used constitutive promoters and achieved only low expression levels, 0.05% of the plasma membrane protein, cf. Table 1. It seems that the high expression level obtained by constitutive expression of the plant H-ATPase is the exception, while a high expression level for Na,K-ATPase and SR-Ca-ATPase is incompatible with constitutive promoters. A probable explanation could be that insertion of H-ATPase into yeast membranes is less prone to eliciting selection for low expressing variants than is expression of the Na,K- or Ca-ATPases. In agreement with these notions, the SR-Ca-ATPase has recently been expressed in a relatively high concentration, 0.3% in the yeast membranes, under control of a galactose-regulated promoter(55) .

For the purification of the recombinant Na,K-ATPase, it was important to establish conditions where the plasma membrane H-ATPase could be removed. This enzyme constitutes background activity in the enzyme assay and [^3H]ATP binding experiments. Fortunately, the H-ATPase turned out to have a relatively high sensitivity to denaturation by incubation with SDS. Our data show that Na and K dependence of ATP hydrolysis, and ATP binding, of the recombinant enzyme are similar to the kinetics of the native renal Na,K-ATPase. In the best of our preparations, the molar activity was close to 7,000 P(i)/min, but the number varied in the range 4,500-7,000 P(i)/min for reasons that are not yet fully understood. A variation in molecular activity is also apparent among the previous preparations from yeast, in the range from 792 to 8212 P(i)/min(1, 15, 56, 57) , cf. Table 1. The relatively large scatter of the reported molecular activity among preparations from different host systems may reflect difficulties in determining site concentrations in preparations with relatively low activity. The highest expression in terms of alpha-subunit protein is achieved in baculovirus-infected Sf-9 cells(9) , but only about 3% of the protein is active in terms of Na,K-ATPase activity and ligand binding, Table 1. The insect cells(9, 43) , as well as the COS-1 (5) and HeLa (10, 20, 58) cells, also express endogenous Na,K-ATPase activity as denoted in Table 1.

The yeast expression system clearly does not distinguish active Na,K-ATPase from inactive mutant alphabeta-units with respect to biosynthesis and translocation to the cell membranes. The D369N and D807N mutations were expressed in yeast membranes at concentrations of alpha-subunit and [^3H]ouabain binding sites that are comparable with those of the wild type enzyme. For the D369N mutant it was further demonstrated that the concentration of protein expressed in the yeast membranes was equal to the concentration of [^3H]ATP sites. The alphabeta-units of the D369N mutant and recombinant Na,K-ATPase have the same hydrodynamic properties as purified Na,K-ATPase from kidney.

Mutation at the phosphorylation site of the negatively charged aspartic acid 369 for an asparagine residue caused a remarkable decrease in dissociation constant of the protein-ATP complex. This is most likely due to a true change in the binding constant of the E(1) conformation for ATP and not to a shift in conformational equilibrium. Our ATP binding data for D369N demonstrate that Na and K stabilize the E(1)Na and E(2)K conformations with widely different affinities to ATP. In addition, the D369N mutant has the same affinity for [^3H]ouabain as the wild type in the presence of Mg. Previous data also show that the [^3H]ouabain complex of the mutant responds to Na and K in the same manner as the wild type Na,K-ATPase(7) . In the Ca-ATPase from SR, modification of either Asp or the neighboring Lys abolish phosphorylation(59) . Our data show that reduction of the negative charge of Asp greatly increases the affinity for ATP. Although the negatively charged Asp residue is essential for enzymatic turnover, it may thus reduce the affinity for ATP through electrostatic repulsion of the negatively charged -phosphate present on the ATP molecule.

The extraordinary high affinities of D369N or D369A for ATP turn these mutants into powerful tools for future identification of residues involved in ATP binding to Na,K-ATPase and for studying the influence of Mg upon ATP binding. Given the high degree of homology of the amino acid sequence around the phosphorylation site (ICS D KTGTLT), it can be expected that the large increase in affinity for ATP upon reducing the negative charge on the phosphorylated side chain will be a general phenomenon for the P-type cation pumps, H,K-ATPase, Ca-ATPase, and H-ATPase.


FOOTNOTES

*
This work was supported by grants from the Danish Natural Science Research Foundation and the Novo Nordic Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

(^1)
The abbreviations used are: bp, base pair(s); PMSF, phenylmethylsulfonyl fluoride; MOPS, 3-(N-morpholino)propanesulfonic acid; MES, 2-(N-morpholino)ethanesulfonic acid.

(^2)
P. A. Pedersen, J. H. Rasmussen, and P. L. Jørgensen, unpublished results.


ACKNOWLEDGEMENTS

We thank David Sørensen and Lilian Beenfeldt for excellent technical assistance and Dr. Steven J. D. Karlish for helpful comments to the manuscript.


REFERENCES

  1. Horowitz, B., Eakle, K. A., Scheiner-Bobis, G., Randolph, G. R., Chen, C. Y., Hitzeman, R. A., and Farley, R. A. (1990) J. Biol. Chem. 265, 4189-4192 [Abstract/Free Full Text]
  2. Jørgensen, P. L. (1982) Biochim. Biophys Acta 694, 27-68 [Medline] [Order article via Infotrieve]
  3. Shull, G. E., Greeb. J., and Lingrel, J. B (1986) Biochemistry 25, 8125-8132 [Medline] [Order article via Infotrieve]
  4. Lingrel, J. B, Orlowski, M., Shull, M. M., and Price, E. M. (1990) Prog. Nucleic Acid Res. Mol. Biol. 38, 37-89 [Medline] [Order article via Infotrieve]
  5. Vilsen, B. (1995) Biochemistry 34, 1455-1463 [Medline] [Order article via Infotrieve]
  6. Price, E. M., and Lingrel, J. B (1988) Biochemistry 27, 8400-8410 [Medline] [Order article via Infotrieve]
  7. Kuntzweiler, T. A., Wallick, E. T., Johnson, C. L., and Lingrel, J. B (1995) J. Biol. Chem. 270, 2993-3000 [Abstract/Free Full Text]
  8. Noguchi, S., Mishina, M., Kawamura, M., and Numa, S. (1987) FEBS Lett. 225, 27-32 [CrossRef][Medline] [Order article via Infotrieve]
  9. DeTomaso, A. W., Xie, Z. J., Liu, G., and Mercer, R. W. (1993) J. Biol. Chem. 268, 1470-1478 [Abstract/Free Full Text]
  10. Jewell, E. A., and Lingrel, J. B (1991) J. Biol. Chem. 266, 16925-16930 [Abstract/Free Full Text]
  11. Blanco, G., Xie, Z. J., and Mercer, R. W. (1993) Proc. Natl. Acad. Aci. U. S. A. 90, 1824-1828 [Abstract]
  12. Price, E. M., and Lingrel, J. B (1988) Biochemistry 27, 8400-8408 [Medline] [Order article via Infotrieve]
  13. Lingrel, J. B, and Kuntzweiler, T. (1994) J. Biol. Chem. 269, 19659-19662 [Free Full Text]
  14. Geering, K. (1990) J. Membr. Biol. 115, 109-121 [Medline] [Order article via Infotrieve]
  15. Eakle, K. A., Kim, K. S., Kabalin, M. A., and Farley, R. A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 2834-2838 [Abstract]
  16. Scheiner-Bobis, G., and Farley, R. A. (1994) Biochim. Biophys. Acta 1193, 226-234 [Medline] [Order article via Infotrieve]
  17. Schultz, L. D., Hofmann, K. J., Mylin, L. M., Montgomery, D. L., Ellis, R. W., and Hopper, J. E. (1987) Gene (Amst.) 61, 123-133
  18. Ohtsubo, M., Noguchi, S., Takeda, K., Morohashi, M., Kawamura, M. (1990) Biochim. Biophys. Acta 1021, 157-160 [Medline] [Order article via Infotrieve]
  19. Jewell-Motz, E. A., and Lingrel, J. B (1993) Biochemistry 32, 13523-13530 [Medline] [Order article via Infotrieve]
  20. Jones, E. W. (1991) Methods Enzymol. 194, 428-453 [Medline] [Order article via Infotrieve]
  21. Wickersham, L. J. (1951) U. S. Dept. Agric. Tech. Bull. 1029
  22. Bullock, W. O., Fernandez, J. M., and Short, J. M. (1987) BioTechniques 5, 376-378
  23. Bertani, G. (1951) J. Bacteriol. 62, 293-300
  24. Becker, D., and Guarante, L. (1991) Methods Enzymol. 194, 182-187 [Medline] [Order article via Infotrieve]
  25. Nishimura, A., Morita, M., Nishimura, Y., and Sugino, Y. (1990) Nucleic Acids Res. 18, 6169 [Medline] [Order article via Infotrieve]
  26. Del Sal, G., Manfioletti, G., and Scheider, C. (1989) BioTechniques 7, 514-519 [Medline] [Order article via Infotrieve]
  27. Rose, M. R., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  29. Ovchinnikov, Y. A., Modyanov, N. N., Broude, N. E., Petrukhin, K. E., Grishin, A. V., Arzamazova, N. M., Aldanova, N. A., Monastyrskaya, G. S., and Sverdlov, E. D. (1986) FEBS Lett. 201, 237-245 [CrossRef][Medline] [Order article via Infotrieve]
  30. Cesareni, G., and Murray, J. A. H. (1987) in Genetic Engineering, Principles and Methods (Setlow, J. K., ed) Vol. 9, pp. 135-149, Plenum Press
  31. Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene (Amst.) 33, 103-119
  32. Baldari and Cesareni (1985) Gene (Amst.) 35, 27-32
  33. Villalba, J. M., Palmgren, M., Berberian, G. E., Ferguson, C., and Serrano, R. (1992) J. Biol. Chem. 267, 12341-12349 [Abstract/Free Full Text]
  34. Chang, A. C. Y., and Cohen, S. N. (1978) J. Bacteriol. 134, 1141-1156 [Medline] [Order article via Infotrieve]
  35. Ho, N. S., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59
  36. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  37. Kyhse-Andersen, J. (1984) J. Biophys. Biochem. Methods 10, 203-209
  38. Jorgensen, P. L. (1974) Biochim. Biophys. Acta 356, 36-52 [Medline] [Order article via Infotrieve]
  39. Jorgensen, P. L. (1988) Methods Enzymol. 156, 29-43 [Medline] [Order article via Infotrieve]
  40. Jorgensen, P. L., and Andersen, J. P. (1986) Biochemistry 25, 2889-2897 [Medline] [Order article via Infotrieve]
  41. Eberhart, E., and Hollenberg, C. P. (1983) J. Bacteriol. 156, 625-635 [Medline] [Order article via Infotrieve]
  42. Pedersen, P. A., and Jorgensen, P. L. (1992) Ann. N. Y. Acad. Sci. 671, 452-455 [Medline] [Order article via Infotrieve]
  43. Blanco, G., Koster, J. C., and Mercer, R. W. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8542-8546 [Abstract]
  44. Norby, J. G., and Jensen, J. (1988) Methods Enzymol. 156, 191-201 [Medline] [Order article via Infotrieve]
  45. Loison, G., Vidal, A., Findeli, A., Roitsch, C., Balloul, J. M., and Lemoine, Y. (1989) Yeast 5, 497-507 [Medline] [Order article via Infotrieve]
  46. Schultz, L. D., Tanner, J., Hofman, K. J., Emini, E. A., Condra, J. H., Jones, R. E., Kieff, E., and Ellis, R. W. (1987) Gene (Amst.) 54, 113-123
  47. Romanos, M. A., Scorer, C. A., and Clare, J. J. (1992) Yeast 8, 423-488 [Medline] [Order article via Infotrieve]
  48. Fukasawa, T., Obonai, K., Segawa, T., and Nogi, Y. (1980) J. Biol. Chem. 255, 2705-2712 [Abstract/Free Full Text]
  49. Janowicz, Z. A., Hening, U., and Hollenberg, C. P. (1982) Gene (Amst.) 20, 347-358
  50. Jabbar, M. A., Sivasubtramanian, N., and Nayak, D. P. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 2019-2023 [Abstract]
  51. Belsham, G. J., Barker, D. E., and Smith, A. E. (1986) Eur. J. Biochem. 156, 413-421 [Abstract]
  52. Purvis, I. J., Loughlin, L., Bettany, A. J., and Brown, A. J. P. (1987) Nucleic Acids Res. 15, 7963-8974 [Abstract]
  53. Palmgren, M. G., and Christensen, G. (1993) FEBS Lett. 317, 216-222 [CrossRef][Medline] [Order article via Infotrieve]
  54. Mahanty, S. K., Rao, U. S., Nicholas, R. A., and Scarborough, G. A. (1994) J. Biol. Chem. 269, 17705-17712 [Abstract/Free Full Text]
  55. Centeno, F., Deschamps, S., Lompré, A. M., Anger, K., Moutin, M. J., Dupont, Y., Palmgren, M. G., Villalba, J. M., Møller, J. V., Falson, P., and leMaire, M. (1994) FEBS Lett. 354, 112-117 [CrossRef]
  56. Wang, K., and Farley, R. A. (1992) J. Biol. Chem. 267, 3577-3580 [Abstract/Free Full Text]
  57. Eakle, K. A., Lyu, R.-M., and Farley, R. A. (1995) J. Biol. Chem. 270, 13937-13947 [Abstract/Free Full Text]
  58. Van Huysse, J. W., Jewell, E. A., and Lingrel, J. B (1993) Biochemistry 32, 819-826 [Medline] [Order article via Infotrieve]
  59. MacLennan, D. H., Clarke, D. M., Loo, T. W., and Skerjanc, I. S. (1992) Acta Physiol. Scand. 146, 141-150 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.